Opportunity Information: Apply for RFA CA 13 013
Apply for RFA CA 13 013
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "NCI Community Oncology Research Program(NCORP) Community Sites (UM1)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.399 Cancer Control.
- This funding opportunity was created on Nov 8, 2013 and posted on Nov 8, 2013.
- Applicants must submit their applications by Jan 8, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: For profit organizations other than small businesses Native American tribal governments (Federally recognized) Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Applicant institutions must be healthcare providing entities (such as consortia of community hospitals and/or oncology practices, integrated care systems, ,etc.) with the exceptions listed below. An NCI funded Cancer Center. A Lead Academic Program (LAP) funded by the Division of Cancer Treatment and Diagnosis (DCTD), NCI. Department of Veterans Affairs hospitals or military treatment facilities are not eligible to apply, but may be included in an application as a member of a consortium led by a qualified applicant, although they may not be the applicant organization or the major contributor to patient accrual. Institutions funded as clinical trials cooperative group affiliate programs are not eligible to apply unless they state in the application that support through this mechanism will be relinquished if a NCORP Community Site cooperative agreement is awarded. Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NCI Community Oncology Research Program (NCORP) Community Sites (UM1) opportunity (Funding Opportunity Number RFA-CA-13-013) is a National Institutes of Health cooperative agreement designed to support community-based healthcare organizations that can participate in a national cancer research network. The main idea behind the program is to bring research opportunities closer to where most patients actually receive care, by strengthening and unifying earlier NCI community research efforts such as the Community Clinical Oncology Program (CCOP), Minority-Based CCOP (MB-CCOP), and the Community Cancer Centers Program (NCCCP). Through NCORP, NCI aimed to create a single, integrated community oncology research platform that connects local hospitals and oncology practices with broader national clinical trial and research infrastructure.
Under this FOA, funded organizations would operate as "NCORP Community Sites" within the larger NCORP network. The research mission centers on four connected priorities. First, community sites would help design and conduct clinical trials focused on cancer prevention, cancer control, and cancer screening, which often involve interventions that can reduce cancer risk, improve early detection, or address symptoms and side effects. Second, NCORP sites would contribute to cancer care delivery research, meaning studies that evaluate how care is organized, financed, accessed, and delivered in real-world practice settings, with the goal of improving quality, outcomes, and efficiency. Third, the program seeks to expand patient and provider access to treatment and imaging trials that are run under the reorganized National Clinical Trials Network (NCTN), effectively linking community practices to major national treatment trials. Fourth, NCORP embeds cancer disparities considerations directly into both clinical trials and cancer care delivery research, so that questions about unequal outcomes, barriers to participation, and differences across populations are not treated as side issues but as core research priorities.
The award mechanism is a cooperative agreement (UM1), which typically means the funded site would not operate in isolation; instead, it would work in close coordination with NCI program staff and other components of the network. While the summary text provided does not list specific budget levels or project periods, the cooperative structure signals ongoing collaboration, shared expectations, and network-level performance requirements that are common for large, multi-site clinical research programs.
Eligibility is broad across many types of U.S.-based organizations, including public and private institutions of higher education, nonprofit organizations (including those with or without 501(c)(3) status), certain for-profit entities (other than small businesses), special district governments, and eligible tribal governments and tribal organizations. The FOA also explicitly recognizes a range of institution types often involved in expanding reach and equity, including HBCUs, Hispanic-Serving Institutions, Tribal Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander-Serving Institutions, as well as faith-based and community-based organizations and certain eligible federal agencies.
At the same time, the FOA sets important boundaries around who can apply. Applicant institutions must be healthcare-providing entities, such as consortia of community hospitals and/or oncology practices or integrated care systems, reflecting the program's emphasis on conducting research in community care settings. Some organizations are specifically excluded from being applicants, including NCI-designated Cancer Centers and NCI-funded Lead Academic Programs (LAPs) funded by NCI's Division of Cancer Treatment and Diagnosis. Department of Veterans Affairs hospitals and military treatment facilities cannot be the applicant organization and cannot be the major source of patient accrual, though they may participate as part of a consortium led by an eligible applicant. The FOA also addresses potential overlap with other trial affiliate mechanisms by stating that institutions already funded as clinical trials cooperative group affiliate programs are not eligible unless they commit to relinquishing that support if they receive an NCORP Community Site award. Foreign institutions and non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
Administratively, the opportunity is categorized as discretionary funding and is associated with multiple cancer-related CFDA numbers (93.393, 93.394, 93.395, 93.399), reflecting its relevance across prevention, detection/diagnosis, treatment, and control research. There is no cost sharing or matching requirement. The FOA was posted on November 8, 2013, with an original and current closing date of January 8, 2014, and an archive date of February 8, 2014. The sponsoring agency is NIH (through NCI), and the full announcement was made available via the NIH grants guide at the provided link. For technical access issues, the listing directs applicants to contact the NIH Office of Extramural Research (OER) webmaster.
FAQs: NCI Community Oncology Research Program (NCORP) Community Sites (UM1) - RFA-CA-13-013
What is the NCORP Community Sites (UM1) funding opportunity?
This opportunity (Funding Opportunity Number RFA-CA-13-013) is a National Institutes of Health (NIH), National Cancer Institute (NCI) cooperative agreement designed to support community-based healthcare organizations that can participate in a national cancer research network as NCORP Community Sites.
What is the goal of NCORP Community Sites?
The goal is to bring cancer research opportunities closer to where most patients receive care by building a single, integrated community oncology research platform. It strengthens and unifies earlier NCI community research efforts, including CCOP, MB-CCOP, and NCCCP, and connects community hospitals and oncology practices to national clinical trial and research infrastructure.
What role would a funded organization play in NCORP?
Funded organizations would operate as "NCORP Community Sites" within the larger NCORP network, participating in network research activities and coordinating with NCI and other network components.
What are the main research priorities supported under this FOA?
The research mission includes four connected priorities: (1) clinical trials focused on cancer prevention, cancer control, and cancer screening; (2) cancer care delivery research; (3) expanding access to treatment and imaging trials run under the National Clinical Trials Network (NCTN); and (4) embedding cancer disparities considerations into both clinical trials and cancer care delivery research.
What kinds of clinical trials are emphasized for NCORP Community Sites?
Community Sites are expected to help design and conduct trials focused on prevention, control, and screening. These studies may involve interventions to reduce cancer risk, improve early detection, or address symptoms and side effects.
What is cancer care delivery research in the context of this opportunity?
Cancer care delivery research refers to studies that evaluate how cancer care is organized, financed, accessed, and delivered in real-world practice settings, with the aim of improving quality, outcomes, and efficiency.
How does this opportunity connect community providers to national treatment trials?
The FOA aims to expand patient and provider access to treatment and imaging trials conducted under the reorganized National Clinical Trials Network (NCTN), linking community practices to major national trials.
How are cancer disparities addressed in this program?
Cancer disparities are treated as core priorities, embedded directly into clinical trials and cancer care delivery research. The program emphasizes studying unequal outcomes, barriers to participation, and differences across populations as central research questions.
What is the award mechanism and what does "UM1 cooperative agreement" imply?
The mechanism is a cooperative agreement (UM1). This typically indicates substantial involvement and close coordination with NCI program staff and other network components, along with shared expectations and network-level performance requirements common in large, multi-site clinical research programs.
Does the provided summary include specific budget levels or project periods?
No. The summary provided does not list specific budget levels or project periods, but it notes the cooperative structure and network-level expectations.
Who is eligible to apply for this NCORP Community Site opportunity?
Eligibility is broad across many types of U.S.-based organizations, including public and private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), certain for-profit entities (other than small businesses), special district governments, and eligible tribal governments and tribal organizations.
Are specific institution types explicitly recognized in the eligibility description?
Yes. The FOA explicitly recognizes institution types often involved in expanding reach and equity, including HBCUs, Hispanic-Serving Institutions, Tribal Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander-Serving Institutions. It also references faith-based and community-based organizations and certain eligible federal agencies.
What is a key eligibility boundary related to being a healthcare provider?
Applicant institutions must be healthcare-providing entities. Examples include consortia of community hospitals and/or oncology practices or integrated care systems, reflecting the focus on conducting research in community care settings.
Which organizations are specifically excluded from applying?
The FOA specifies that NCI-designated Cancer Centers and NCI-funded Lead Academic Programs (LAPs) funded by NCI's Division of Cancer Treatment and Diagnosis are not eligible to be applicants.
Can Department of Veterans Affairs (VA) hospitals or military treatment facilities apply?
No. VA hospitals and military treatment facilities cannot be the applicant organization and cannot be the major source of patient accrual. However, they may participate as part of a consortium led by an eligible applicant.
How does the FOA handle overlap with clinical trials cooperative group affiliate program support?
Institutions already funded as clinical trials cooperative group affiliate programs are not eligible unless they commit to relinquishing that support if they receive an NCORP Community Site award.
Are foreign institutions or non-U.S. components eligible?
No. Foreign institutions and non-U.S. components of U.S. organizations are not eligible. Foreign components (as defined by NIH policy) are not allowed.
Is cost sharing or matching required?
No. The FOA states there is no cost sharing or matching requirement.
What type of funding category is this opportunity?
The opportunity is categorized as discretionary funding.
Which CFDA numbers are associated with this opportunity?
The opportunity is associated with multiple cancer-related CFDA numbers: 93.393, 93.394, 93.395, and 93.399.
When was the FOA posted and what were the key dates?
The FOA was posted on November 8, 2013. The original and current closing date was January 8, 2014. The archive date was February 8, 2014.
Which agency sponsors this opportunity?
The sponsoring agency is NIH through the National Cancer Institute (NCI).
Where was the full announcement made available?
The full announcement was made available via the NIH grants guide at the provided link in the opportunity listing.
Who should be contacted for technical access issues related to the announcement listing?
For technical access issues, the listing directs applicants to contact the NIH Office of Extramural Research (OER) webmaster.
Browse more opportunities from the same category: Education Health
Next opportunity: NCI Community Oncology Research Program (NCORP) Research Bases (UM1)
Previous opportunity: Veteran Women Igniting the Spirit of Entrepreneurship Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 13 013
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 13 013) also looked into and applied for these:
| Funding Opportunity |
|---|
| NCI Community Oncology Research Program (NCORP) Research Bases (UM1) Apply for RFA CA 13 012 Funding Number: RFA CA 13 012 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (UM1) Apply for RFA CA 13 014 Funding Number: RFA CA 13 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exceptional Unconventional Research Enabling Knowledge Acceleration (EUREKA) for Neuroscience and Disorders of the Nervous System (R01) Apply for RFA MH 14 214 Funding Number: RFA MH 14 214 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Indo US Collaborative Program on Affordable Medical Devices (R03) Apply for PAR 13 390 Funding Number: PAR 13 390 Agency: National Institutes of Health Category: Education Health Funding Amount: $75,000 |
| NCI Small Grants Program for Cancer Research (NCI Omnibus R03) Apply for PAR 14 007 Funding Number: PAR 14 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Identification of Gene Variants for Addiction Related Traits by Next Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3) Apply for PAR 14 010 Funding Number: PAR 14 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $125,000 |
| The Palliative Care Research Cooperative (PCRC) Enhancing Sustainability and Building the Science of Palliative Care (R01) Apply for RFA NR 14 003 Funding Number: RFA NR 14 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Revision Applications for Research on Genomic Underpinnings of Response to Rehabilitation Interventions (R01) Apply for PAR 14 012 Funding Number: PAR 14 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Genomic Underpinnings of Response to Rehabilitation Interventions (R01) Apply for PAR 14 011 Funding Number: PAR 14 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Functional Genetics, Epigenetics, and Non coding RNAs in Substance Abuse (R01) Apply for PA 14 014 Funding Number: PA 14 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Functional Genetics, Epigenetics, and Non coding RNAs in Substance Abuse (R21) Apply for PA 14 013 Funding Number: PA 14 013 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Public Health Impact of the Changing Policy/Legal Environment for Marijuana (R01) Apply for PAS 14 020 Funding Number: PAS 14 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Discovering Novel Targets The Molecular Genetics of Drug Addiction and Related Co Morbidities (R01) Apply for PA 14 025 Funding Number: PA 14 025 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Basic Mechanisms of Brain Development for Substance Use and Dependence (R01) Apply for PA 14 026 Funding Number: PA 14 026 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50) Apply for PAR 14 031 Funding Number: PAR 14 031 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Chronic Illness Self Management in Children and Adolescents (R01) Apply for PA 14 029 Funding Number: PA 14 029 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Chronic Illness Self Management in Children and Adolescents (R21) Apply for PA 14 030 Funding Number: PA 14 030 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Reducing Health Disparities Among Minority and Underserved Children (R21) Apply for PA 14 034 Funding Number: PA 14 034 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Reducing Health Disparities Among Minority and Underserved Children (R01) Apply for PA 14 033 Funding Number: PA 14 033 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Women Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) Apply for PA 14 036 Funding Number: PA 14 036 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 13 013", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.